Research and Markets (http://www.researchandmarkets.com/research/dnb8jz/retinal) has announced the addition of the "Retinal Degeneration-Pipeline Insights, 2016" report to their offering.
Retinal Degeneration-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Retinal Degeneration. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Retinal Degeneration. The report also assesses the Retinal Degeneration therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope of the Report:
- The report provides competitive pipeline landscape of Retinal Degeneration
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Retinal Degeneration pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Retinal Degeneration and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Retinal Degeneration Overview
- Retinal Degeneration Pipeline Therapeutics
- Retinal Degeneration Therapeutics under Development by Companies
- Retinal Degeneration Filed and Phase III Products
- Comparative Analysis
- Retinal Degeneration Phase II Products
- Comparative Analysis
- Retinal Degeneration Phase I and IND Filed Products
- Comparative Analysis
- Retinal Degeneration Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Retinal Degeneration - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Retinal Degeneration - Discontinued Products
- Retinal Degeneration - Dormant Products
-
Companies Involved in Therapeutics Development for Retinal Degeneration
For more information visit http://www.researchandmarkets.com/research/dnb8jz/retinal
View source version on businesswire.com: http://www.businesswire.com/news/home/20160129005383/en/